marginally significantp < 0.20
Any biomarker with a marginally significant p value ( p < 0.20) for either a main effect or interaction will be eligible for the risk stratification model and continued in the Validation Phase.
Any biomarker with a marginally significant p value ( p < 0.20) for either a main effect or interaction will be eligible for the risk stratification model and continued in the Validation Phase.